200 related articles for article (PubMed ID: 28832354)
21. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
[TBL] [Abstract][Full Text] [Related]
22. Autologous transplantation and management of younger patients with mantle cell lymphoma.
Geisler CH
Best Pract Res Clin Haematol; 2012 Jun; 25(2):211-20. PubMed ID: 22687457
[TBL] [Abstract][Full Text] [Related]
23. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
Avivi I; Goy A
Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
[TBL] [Abstract][Full Text] [Related]
24. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma.
Frosch Z; Luskin MR; Landsburg DJ; Schuster SJ; Svoboda J; Loren AW; Porter DL; Stadtmauer EA; Nasta SD
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):92-7. PubMed ID: 25174772
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
Metzner B; Müller TH; Casper J; Kimmich C; Köhne CH; Petershofen E; Renzelmann A; Thole R; Voss A; Dreyling M; Hoster E; Klapper W; Pott C
Eur J Haematol; 2023 Aug; 111(2):220-228. PubMed ID: 37094812
[TBL] [Abstract][Full Text] [Related]
26. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
[TBL] [Abstract][Full Text] [Related]
27. Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.
Touzeau C; Leux C; Bouabdallah R; Roussel M; Delarue R; Bouabdallah K; Thieblemont C; Cacheux V; Cartron G; Compain L; Gyan E; Morschhauser F; Casasnovas O; Moles MP; Michallet AS; Gressin R; Damaj G; Rose C; Sirvent A; Hermine O; Mohty M; Milpied N; Le Gouill S
Ann Hematol; 2014 Feb; 93(2):233-42. PubMed ID: 24563925
[TBL] [Abstract][Full Text] [Related]
28. Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.
Touzeau C; Leux C; Bouabdallah R; Roussel M; Delarue R; Bouabdallah K; Thieblemont C; Cacheux V; Cartron G; Compain L; Gyan E; Morschhauser F; Casasnovas O; Moles MP; Michallet AS; Gressin R; Damaj G; Rose C; Sirvent A; Hermine O; Mohty M; Milpied N; Le Gouill S
Ann Hematol; 2014 Feb; 93(2):233-42. PubMed ID: 23949376
[TBL] [Abstract][Full Text] [Related]
29. Evolving treatment strategies in mantle cell lymphoma.
Edwin NC; Kahl B
Best Pract Res Clin Haematol; 2018 Sep; 31(3):270-278. PubMed ID: 30213396
[TBL] [Abstract][Full Text] [Related]
30. Counterpoint: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: The Pendulum Swings Again: Time to Reassess the Role of ASCT in First Complete Remission.
Gordon LI
Oncology (Williston Park); 2016 Dec; 30(12):1055, 1060-2. PubMed ID: 27987197
[No Abstract] [Full Text] [Related]
31. [Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches].
Klener P; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
[TBL] [Abstract][Full Text] [Related]
32. CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma.
Berger MD; Branger G; Leibundgut K; Baerlocher GM; Seipel K; Mueller BU; Gregor M; Ruefer A; Pabst T
Leuk Res; 2015 Jun; 39(6):561-7. PubMed ID: 25890431
[TBL] [Abstract][Full Text] [Related]
33. Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphoma.
Karmali R; Abramson JS; Stephens DM; Barnes J; Winter JN; Ma S; Gao J; Kaplan J; Petrich AM; Hochberg E; Takvorian T; Mi X; Nelson V; Gordon LI; Pro B
Blood Adv; 2023 Dec; 7(23):7361-7368. PubMed ID: 37756532
[TBL] [Abstract][Full Text] [Related]
34. Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation.
Klener P; Salek D; Pytlik R; Mocikova H; Forsterova K; Blahovcova P; Campr V; Prochazka V; Obr A; Jaksa R; Kuntscherova J; Boudová L; Kodet R; Janikova A; Trneny M
Am J Hematol; 2019 Feb; 94(2):E50-E53. PubMed ID: 30474171
[No Abstract] [Full Text] [Related]
35. Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma.
Tsirigotis P; Dray L; Resnick IB; Ackerstein A; Gesundheit B; Elad S; Or R; Shapira MY
Ann Hematol; 2010 Mar; 89(3):263-72. PubMed ID: 19693502
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.
Falcone U; Jiang H; Bashir S; Tsang R; Kukreti V; Keating A; Crump M; Kuruvilla J
Bone Marrow Transplant; 2018 Mar; 53(3):347-351. PubMed ID: 29269808
[No Abstract] [Full Text] [Related]
37. What is the role of autologous transplant for lymphoma in the current era?
Stiff P
Hematology Am Soc Hematol Educ Program; 2015; 2015():74-81. PubMed ID: 26637704
[TBL] [Abstract][Full Text] [Related]
38. Blood or marrow transplantation for mantle cell lymphoma.
Kasamon YL
Curr Opin Oncol; 2007 Mar; 19(2):128-35. PubMed ID: 17272985
[TBL] [Abstract][Full Text] [Related]
39. Controversies in lymphoma: the role of hematopoietic cell transplantation for mantle cell lymphoma and peripheral T cell lymphoma.
Dreger P; Laport GG
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):100-7. PubMed ID: 18162229
[TBL] [Abstract][Full Text] [Related]
40. A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.
Armand P; Redd R; Bsat J; Mayuram S; Giardino A; Fisher DC; LaCasce AS; Jacobson C; Davids MS; Brown JR; Weng L; Wilkins J; Faham M; Freedman AS; Joyce R; Jacobsen ED
Br J Haematol; 2016 Apr; 173(1):89-95. PubMed ID: 26729345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]